Page 160 - Q26 -

¥ÿ≈æ“À

United Nations Development Programme (UNDP). Good Practice Guide:

Improving Access To Treatment By Utilizing Public Health Flexibilities

In The WTO TRIPS Agreement, 2010.

Said, Mohamad El, and Amy Kapczynski. çAccess to Medicines: The Role

of Intellectual Property Law and Policy.é†Working Paper Prepared for

the Third Meeting of the Technical Advisory Group of the Global

Commission on HIV and the Law, 2011.

Sawicka, Monika, and Ron A. Bouchard. çEmpirical Analysis of Canadian Drug
Approval Data 2001-2008: Are Pharmaceutical Players ùDoing More with

Lessû?.é†MCGILL JOURNAL OF LAW AND HEALTH / REVUE DE

DROIT ET SANTÉ DE MCGILL†3 (2009): 85.

Shadlen, Kenneth C., and S. Guennif.†Intellectual Property, Pharmaceuticals

and Public Health: Access to Drugs in Developing Countries. Edward

Elgar Publishing, 2011.

Sooksriwong, Cha-oncin. çMedicine Prices in Thailand: A Result of No

Medicine Pricing Policy.é†Southern Med Review†2, no. 2 (2009): 13.

Tunsarawut, Sinfah. çEvergreened Patents Cause Unwarranted High Drug Prices,
Hinder Growth Of Local Producers -NGOs, Thai Producers Claim.é

Intellectual Property Watch, 2018. http://www.ip-watch.org/2018/05/07/

evergreened-patents-cause-unwarranted-high-drug-prices-hinder-growth-

local-producers-ngos-thai-producers-claim/.

World Health Organisation.†Commission on Intellectual Property Rights,

Innovation. and Public Health, Public Health, Innovation and Intellectual

¡°√“§¡ - ‡¡…“¬π ÚıˆÛ 149